CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Returned to the company President & C.E.O. returned 11,025 shares (to the company)
- 4 Returned to the company E.V.P., General Counsel returned 6,314 shares (to the company)
- 4 Returned to the company Exec. VP International Ops returned 5,101 shares (to the company)
- 4 Returned to the company President Myriad Oncology returned 844 shares (to the company)
- 4 Returned to the company President, MGL returned 1,830 shares (to the company)
- 4 Returned to the company President Myriad RBM, Inc. returned 3,148 shares (to the company)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Scientific Officer sold 50,000 shares at $43.34 ($2,167,040)
- 4 Open-market sale Director sold 30,000 shares at an average $42.06 ($1,261,785)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale E.V.P., General Counsel sold 70,672 shares at an average $42.88 ($3,030,220)
- 4 Open-market sale President & C.E.O. sold 80,000 shares at $41.00 ($3,280,000)
- 4 Open-market sale Chief Scientific Officer sold 60,000 shares at $40.12 ($2,407,200)
- 4 Open-market sale E.V.P., General Counsel sold 33,000 shares at $40.00 ($1,320,000)
- 4 Open-market sale Director sold 20,369 shares at an average $39.35 ($801,594)
- 4 Open-market sale Director sold 30,000 shares at an average $39.69 ($1,190,589)
- 4 Open-market sale Director sold 49,631 shares at an average $39.30 ($1,950,277)
- 4 Open-market sale President & C.E.O. sold 90,000 shares at $38.00 ($3,420,000)
- 4 Open-market sale E.V.P., General Counsel sold 33,139 shares at $38.00 ($1,259,282)
- 4 Open-market sale Director sold 10,000 shares at $37.92 ($379,245)
Page 27 of 65 · 1,294 filings